BioRestorative Therapies, Inc. 10-Q filing
Filed 2026-05-14 · Report date 2026-03-31 · 2026
Filing metadata
- Accession number
- 0001493152-26-023126
- Form type
- 10-Q
- CIK
- 0001505497
- Primary document
- https://www.sec.gov/Archives/edgar/data/1505497/000149315226023126/form10-q.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for BioRestorative Therapies, Inc..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Revenue | $23,170 | - | - |
| Cost Of Revenue | $7,385 | - | - |
| Gross Profit | $15,785 | - | - |
| Operating Income | $-3.4M | - | - |
| Net Income | $-2.2M | - | - |
| Eps Basic | -0.12 | - | - |
| Eps Diluted | -0.12 | - | - |
| Cash And Equivalents | $3.1M | - | - |
| Total Assets | $4.6M | - | - |
| Shareholders Equity | $3.0M | - | - |
| Operating Cash Flow | $-3.8M | - | - |
| Capital Expenditures | $36,400 | - | - |